5,171 research outputs found
Recommended from our members
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
Accelerating cures for children with cancer remains an immediate challenge as a result of extensive oncogenic heterogeneity between and within histologies, distinct molecular mechanisms evolving between diagnosis and relapsed disease, and limited therapeutic options. To systematically prioritize and rationally test novel agents in preclinical murine models, researchers within the Pediatric Preclinical Testing Consortium are continuously developing patient-derived xenografts (PDXs)-many of which are refractory to current standard-of-care treatments-from high-risk childhood cancers. Here, we genomically characterize 261 PDX models from 37 unique pediatric cancers; demonstrate faithful recapitulation of histologies and subtypes; and refine our understanding of relapsed disease. In addition, we use expression signatures to classify tumors for TP53 and NF1 pathway inactivation. We anticipate that these data will serve as a resource for pediatric oncology drug development and will guide rational clinical trial design for children with cancer
SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis
SETD2, a H3K36 trimethyltransferase, is the most frequently mutated epigenetic modifier in lung adenocarcinoma, with a mutation frequency of approximately 9%. However, how SETD2 loss of function promotes tumorigenesis remains unclear. Using conditional Setd2-KO mice, we demonstrated that Setd2 deficiency accelerated the initiation of KrasG12D-driven lung tumorigenesis, increased tumor burden, and significantly reduced mouse survival. An integrated chromatin accessibility and transcriptome analysis revealed a potentially novel tumor suppressor model of SETD2 in which SETD2 loss activates intronic enhancers to drive oncogenic transcriptional output, including the KRAS transcriptional signature and PRC2-repressed targets, through regulation of chromatin accessibility and histone chaperone recruitment. Importantly, SETD2 loss sensitized KRAS-mutant lung cancer to inhibition of histone chaperones, the FACT complex, or transcriptional elongation both in vitro and in vivo. Overall, our studies not only provide insight into how SETD2 loss shapes the epigenetic and transcriptional landscape to promote tumorigenesis, but they also identify potential therapeutic strategies for SETD2 mutant cancers
Transcriptional regulation of the human pre-implantation embryo
Millions of couples worldwide have difficulties in conceiving a child. These couples, affected by infertility, suffer from symptoms of stress. The causes of infertility are largely unknown and current available treatment, in vitro fertilization has moderate success rates. The in vitro fertilization covers pre-implantation stage of the human embryo development. Better understanding of the molecular mechanisms in the early development might help to improve the in vitro fertilization methods.
Much of the knowledge on early development has been gained from model organisms: nematode, fruit fly, zebrafish and mouse. Mouse is a commonly used model organism for mammalian pre-implantation development. Global gene expression studies have been performed on mouse and human. Overall, gene expression changes seem to be similar in principle between the organisms. However, the expression of the first transcribed genes in the early development may not be as conserved between species as other genes expressed later in development. Therefore, human pre-implantation development should also be studied on human material for better translation of the results.
Genes with a dynamic expression profile in human pre-implantation development were identified in Paper I. Various criteria such as conservation, expression profile in mouse, relevance in cancer and novelty were applied to choose seventy genes of potential importance in human early development. Expression of those genes was studied in mouse and compared with human orthologues. The results showed differences in the expression profiles between human and mouse.
Paper II found novel regulatory elements and potentially important transcription factors from human early development by single-cell RNA sequencing. About 350 of oocytes and blastomeres from early embryos were studied, the promoters of activated genes were analyzed, and many PRD-like homeodomain genes with first-time evidence of expression were cloned. These genes were suggested to regulate the early development.
Paper III describes the expression pattern, target genes and potential function in early development for the PRD-like homeodomain gene LEUTX. A novel variant of LEUTX was identified and cloned, providing a full homeodomain-containing and functional isoform of the protein. LEUTX was found expressed exclusively in human pre-implantation embryos. The target genes of LEUTX were enriched among the genes activated by human embryo, which strongly indicated regulatory function for LEUTX in the early development.
The other PRD-like homeodomain containing proteins were studied in Paper IV. Expression of those genes was found to be specific for early development. The targets of CPHX1 and DPRX were found to be enriched among the genes activated in the early human embryo. General overlap of the target genes allowed for discussion of their possible functional redundancy.
The thesis offers novel findings for understanding gene expression and regulation in human pre-implantation embryos. The studies identify novel PRD-like homeodomain containing transcription factors that may have a crucial importance in the regulation of gene expression in the human pre-implantation embryos
Exploring the regulatory changes underlying the head to trunk developmental transition
Although vertebrates display a wide diversity of body shapes and sizes their basic body plan is consistently organized into head, neck, trunk and tail structures. During development, the vertebrate main body axis is generated sequentially from head to tail, first by the activity of the primitive streak and later on by the tail bud. Progenitors within these regions, located at the posterior embryonic end, progressively supply cells that will build the different body tissues as the embryo extends along its main body axis. Although this is a continuous process, head and trunk development is controlled by distinct gene regulatory networks that lead to differing cell dynamics and generation of specific tissues
Whole transcriptome profiling reveals the RNA content of motor axons
Most RNAs within polarized cells such as neurons are sorted subcellularly in a coordinated manner. Despite advances in the development of methods for profiling polyadenylated RNAs from small amounts of input RNA, techniques for profiling coding and non-coding RNAs simultaneously are not well established. Here, we optimized a transcriptome profiling method based on double-random priming and applied it to serially diluted total RNA down to 10 pg. Read counts of expressed genes were robustly correlated between replicates, indicating that the method is both reproducible and scalable. Our transcriptome profiling method detected both coding and long non-coding RNAs sized >300 bases. Compared to total RNAseq using a conventional approach our protocol detected 70% more genes due to reduced capture of ribosomal RNAs. We used our method to analyze the RNA composition of compartmentalized motoneurons. The somatodendritic compartment was enriched for transcripts with post-synaptic functions as well as for certain nuclear non-coding RNAs such as 7SK. In axons, transcripts related to translation were enriched including the cytoplasmic non-coding RNA 7SL. Our profiling method can be applied to a wide range of investigations including perturbations of subcellular transcriptomes in neurodegenerative diseases and investigations of microdissected tissue samples such as anatomically defined fiber tracts
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice
BACKGROUND: Parkinson's disease (PD), the second most frequent neurodegenerative disorder at old age, can be caused by elevated expression or the A53T missense mutation of the presynaptic protein alpha-synuclein (SNCA). PD is characterized pathologically by the preferential vulnerability of the dopaminergic nigrostriatal projection neurons. METHODOLOGY/PRINCIPAL FINDINGS: Here, we used two mouse lines overexpressing human A53T-SNCA and studied striatal dysfunction in the absence of neurodegeneration to understand early disease mechanisms. To characterize the progression, we employed young adult as well as old mice. Analysis of striatal neurotransmitter content demonstrated that dopamine (DA) levels correlated directly with the level of expression of SNCA, an observation also made in SNCA-deficient (knockout, KO) mice. However, the elevated DA levels in the striatum of old A53T-SNCA overexpressing mice may not be transmitted appropriately, in view of three observations. First, a transcriptional downregulation of the extraneural DA degradation enzyme catechol-ortho-methytransferase (COMT) was found. Second, an upregulation of DA receptors was detected by immunoblots and autoradiography. Third, extensive transcriptome studies via microarrays and quantitative real-time RT-PCR (qPCR) of altered transcript levels of the DA-inducible genes Atf2, Cb1, Freq, Homer1 and Pde7b indicated a progressive and genotype-dependent reduction in the postsynaptic DA response. As a functional consequence, long term depression (LTD) was absent in corticostriatal slices from old transgenic mice. CONCLUSIONS/SIGNIFICANCE: Taken together, the dysfunctional neurotransmission and impaired synaptic plasticity seen in the A53T-SNCA overexpressing mice reflect early changes within the basal ganglia prior to frank neurodegeneration. As a model of preclinical stages of PD, such insights may help to develop neuroprotective therapeutic approaches
Recommended from our members
The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma.
Despite major advances in targeted melanoma therapies, drug resistance limits their efficacy. Long noncoding RNAs (lncRNAs) are transcriptome elements that do not encode proteins but are important regulatory molecules. LncRNAs have been implicated in cancer development and response to different therapeutics and are thus potential treatment targets; however, the majority of their functions and molecular interactions remain unexplored. In this study, we identify a novel cytoplasmic intergenic lincRNA (MIRAT), which is upregulated following prolonged MAPK inhibition in NRAS mutant melanoma and modulates MAPK signaling by binding to the MEK scaffold protein IQGAP1. Collectively, our results present MIRAT's direct modulatory effect on the MAPK pathway and highlight the relevance of cytoplasmic lncRNAs as potential targets in drug resistant cancer
The laminA/NF-Y protein complex reveals an unknown transcriptional mechanism on cell proliferation
Lamin A is a component of the nuclear matrix that also controls proliferation by
largely unknown mechanisms. NF-Y is a ubiquitous protein involved in cell proliferation
composed of three subunits (-YA -YB -YC) all required for the DNA binding and
transactivation activity. To get clues on new NF-Y partner(s) we performed a mass
spectrometry screening of proteins that co-precipitate with the regulatory subunit
of the complex, NF-YA. By this screening we identified lamin A as a novel putative
NF-Y interactor. Co-immunoprecipitation experiments and confocal analysis confirmed
the interaction between the two endogenous proteins. Interestingly, this association
occurs on euchromatin regions, too. ChIP experiments demonstrate lamin A
enrichment in several promoter regions of cell cycle related genes in a NF-Y dependent
manner. Gain and loss of function experiments reveal that lamin A counteracts NF-Y
transcriptional activity. Taking advantage of a recently generated transgenic reporter
mouse, called MITO-Luc, in which an NF-Y–dependent promoter controls luciferase
expression, we demonstrate that lamin A counteracts NF-Y transcriptional activity
not only in culture cells but also in living animals. Altogether, our data demonstrate
the occurrence of lamin A/NF-Y interaction and suggest a possible role of this protein
complex in regulation of NF-Y function in cell proliferatio
- …